Effects of IC With and Without MET on Upper Trapezius Trigger Points

April 6, 2023 updated by: University of Lahore

Effects of Ischemic Compression With and Without Muscle Energy Technique on Pain, Range of Motion and Functional Disability in Patients With Trigger Points in Upper Trapezius; A Randomized Clinical Trial

the aim of the study is to check the effects of ischemic compression with and without muscle energy technique on Pain, Range of motion, and Functional Disability on myofascial trigger points in the upper trapezius. In previous studies, Muscle Energy Technique and Ischemic Compression are compared with different conventional and combined therapy approaches, including most of the techniques used to treat Trigger Points in the upper trapezius. No study has evaluated the effects of ischemic compression with and without muscle energy technique on Pain, Range of motion, and Functional Disability on myofascial trigger points in the upper trapezius. The outcome measures are a Numeric pain rating scale, universal goniometer and neck disability index questionnaire.

Study Overview

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Muhammad Haider Ullah Khan, MSPT(neuro)
  • Phone Number: 00923314127210
  • Email: haiderullah@live.com

Study Locations

    • Punjab
      • Sialkot, Punjab, Pakistan
        • University of Sialkot

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both gender Aged 18 to 50 years (40)
  • Participants with active myofascial trigger points in the upper trapezius diagnosed by a senior physiotherapist on the basis of Travel and Simon criteria will be randomly allocated into two clinical groups.
  • Taut band having palpable nodule within upper trapezius muscle
  • Pain produced in a specific pattern which is radiating in character when firm pressure is applied on trigger points

Exclusion Criteria:

  • Trauma (whiplash injury)
  • Injury to Cervical Spine
  • Cervical Spine surgery
  • Cervical Myelopathy and Radiculopathy
  • Osteoporosis of the cervical spine
  • Cervical myeloma
  • Complex regional pain syndrome
  • Patients with the H/O any Neurological, Rheumatology and other serious medical illnesses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Ischemic Compression
Ischemic Compression will be applied to the upper trapezius trigger points in patients recruited in group 1.
It includes conventional Physical therapy, hot packs (75°C) for 20 minutes, and active stretching exercises for the upper trapezius muscle (slow, 5 repetitions per session, 10-second hold, and 10-second relaxation between two repetitions) as a baseline treatment. For the Ischemic compression, the patient will be in the supine position with the cervical spine in opposite lateral flexion to the treating part so that the upper trapezius muscle fibers were kept in a lengthened position physiotherapist will apply gradually increasing pressure to the Trigger points until the subject perceived the first noticeable pain. At that moment, the pressure will be maintained until the discomfort and/or pain eased by around 50% as perceived by the patient, at which time the pressure will be increased until the discomfort appears again. This process will be maintained for 90 seconds.
Experimental: Ischemic compression and Muscle Energy Technique
ischemic compression along with muscle energy technique will be applied to the upper trapezius trigger points in patients allocated to group 2.
The Participants will receive all the treatments given to the active comparator group and they will also receive the Muscle Energy Technique treatment in supine position and the practitioner will stabilize the shoulder of the affected side with one hand, while the ear/mastoid area of the affected side will be held by the opposite hand. The head and neck were then bent towards the contralateral side, flexed, and ipsilaterally rotated. The subjects will then shrug the stabilized shoulder towards the ear at a sub-maximal pain-free effort (20% of the available strength). The isometric contraction will be held for 7-10s. This position will be maintained for 30 seconds and repeated three to five times per treatment session. Treatment sessions will be given on alternate days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in pain on Numeric Pain Rating Scale at week 4
Time Frame: Baseline and week 4
on a scale of 1 to 10, o means no pain while 10 means worst pain
Baseline and week 4
Change from Baseline in Goniometer readings at week 4
Time Frame: Baseline and week 4
for flexion any value less than 90 degrees indicates limited range of motion, for extension any value less than 70 indicates limited range of motion, for lateral flexion values less than 20 and greater than 45 considered limited, for rotation value less than 90 is considered limited
Baseline and week 4
Change from baseline in Neck disability index questionnaire scores at week 4
Time Frame: Baseline and week 4
on a scale of 0 to 50, 0 indicates no disability and 50 indicates completely disabled
Baseline and week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain on Numeric Pain Rating Scale at week 2
Time Frame: week 2
on a scale of 1 to 10, o means no pain while 10 means worst pain
week 2
Goniometer readings at week 2
Time Frame: week 2
Using goniometer, neck ranges of motion will be measured. for flexion any value less than 90 degrees indicates limited range of motion, for extension any value less than 70 indicates limited range of motion, for lateral flexion values less than 20 and greater than 45 considered limited, for rotation value less than 90 is considered limited
week 2
Neck disability index questionnaire scores at week 2
Time Frame: week 2
on a scale of 0 to 50, 0 indicates no disability and 50 indicates completely disabled
week 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Syeda Khadija Kazmi, DPT, The University of Lahore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2021

Primary Completion (Actual)

June 17, 2022

Study Completion (Actual)

June 23, 2022

Study Registration Dates

First Submitted

June 8, 2022

First Submitted That Met QC Criteria

June 8, 2022

First Posted (Actual)

June 13, 2022

Study Record Updates

Last Update Posted (Actual)

April 7, 2023

Last Update Submitted That Met QC Criteria

April 6, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-UOL-FAHS/890-II/2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Trapezius Trigger Points

Clinical Trials on Ischemic Compression

3
Subscribe